Breaking News Instant updates and real-time market news.

PTN

Palatin

$0.33

-0.007 (-2.07%)

, AMAG

AMAG Pharmaceuticals

07:37
03/20/17
03/20
07:37
03/20/17
07:37

Palatin: USPTO isses Notice of Allowance for patent serial number 14/704,223

Palatin Technologies (PTN) announced that the United States Patent and Trademark Office has issued a Notice of Allowance for U.S. Patent Application Serial Number 14/704,223. The allowed claims are for methods of treating female sexual dysfunction and hypoactive sexual desire disorder with bremelanotide, an investigational product designed for on-demand treatment of HSDD in premenopausal women. Once issued, the patent will have a term to November 2033. Stephen Wills, COO and CFO of Palatin, commented, "We are pleased to have received a notice of allowance from the USPTO, which signifies that a patent can be granted from an application. We believe that this patent, with a term out to 2033, further strengthens the intellectual property portfolio for the bremelanotide development program." Palatin previously announced positive Phase 3 results with bremelanotide for treating HSDD in premenopausal women. Palatin has entered into an agreement with AMAG Pharmaceuticals (AMAG) granting AMAG exclusive North American rights to develop and commercialize bremelanotide.

PTN

Palatin

$0.33

-0.007 (-2.07%)

AMAG

AMAG Pharmaceuticals

PTN Palatin
$0.33

-0.007 (-2.07%)

11/02/16
ROTH
11/02/16
NO CHANGE
Target $7
ROTH
Buy
Palatin price target raised to $7 from $4 at Roth Capital
01/10/17
LEER
01/10/17
DOWNGRADE
Target $25
LEER
Market Perform
AMAG Pharmaceuticals downgraded to Market Perform from Outperform at Leerink
Leerink analyst Joseph Schwartz downgraded AMAG Pharmaceuticals (AMAG) to Market Perform from Outperform after the company provided a "disappointing update" related to the Makena auto-injector program. Furthermore, the analyst notes that the licensing agreement with Palatin (PTN) for its hypoactive sexual desire disorder drug Rekynda could drive incremental value but will require "sizable upfront investment" and have to clear regulatory and commercialization hurdles before that takes place. Nonetheless, Schwartz notes that AMAG's preliminary Q4 results and FY17 financial estimates were in-line with his bullish outlook for 2016-2017. He also lowered his price target on AMAG's shares to $25 from $39.
AMAG AMAG Pharmaceuticals

01/10/17
NEED
01/10/17
DOWNGRADE
NEED
Hold
AMAG Pharmaceuticals downgraded to Hold from Buy at Needham
01/31/17
JPMS
01/31/17
NO CHANGE
Target $24
JPMS
Neutral
AMAG Pharmaceuticals price target lowered to $24 from $33 at JPMorgan
JPMorgan analyst Jessica Fye lowered her price target for AMAG Pharmaceuticals to $24 following updates at her firm's healthcare conference, including the shift in Makena strategy, Rekynda in-licensing and 2017 guidance. The analyst keeps a Neutral rating on the shares.
02/03/17
COWN
02/03/17
DOWNGRADE
Target $25
COWN
Market Perform
AMAG Pharmaceuticals downgraded to Market Perform from Outperform at Cowen
Cowen analyst Ken Cacciatore downgraded AMAG Pharmaceuticals to Market Perform from Outperform on the belief that the franchise extension strategy for Makena will unfortunately fail. The analyst also questions the business decisions made after acquiring Makena, such as buying CBR, which could prove to be value destroying. Cacciatore lowered his price target to $25 from $35 on AMAG Pharmaceuticals shares.
03/15/17
RAJA
03/15/17
NO CHANGE
RAJA
Raymond James says new study highlights risks for AMAG
Raymond James analyst Christopher Raymond says a new study in the American Journal of Obstetrics and Gynecology questions the therapeutic utility of hydroxyprogesterone caproate for preterm birth also highlights a potential safety signal. Hydroxyprogesterone caproate is the active ingredient in AMAG Pharmaceuticals' Makena. The analyst has an Underpeform rating on the shares.

TODAY'S FREE FLY STORIES

12:15
03/23/17
03/23
12:15
03/23/17
12:15
General news
Treasury Action: bonds are in limbo awaiting results the House ACA vote »

Treasury Action: bonds…

12:15
03/23/17
03/23
12:15
03/23/17
12:15
General news
Breaking General news story  »

Minneapolis Federal…

Z

Zillow

$35.29

0.12 (0.34%)

12:11
03/23/17
03/23
12:11
03/23/17
12:11
Options
Bearish flow in Zillow as shares falter »

Bearish flow in Zillow as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    May

12:10
03/23/17
03/23
12:10
03/23/17
12:10
General news
U.S. equities are dusting themselves off »

U.S. equities are dusting…

ATEC

Alphatec

$2.68

-0.12 (-4.29%)

12:08
03/23/17
03/23
12:08
03/23/17
12:08
Syndicate
Alphatec announces $18.9M private placement »

H.C. Wainwright is acting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OA

Orbital ATK

$99.47

-0.075 (-0.08%)

12:08
03/23/17
03/23
12:08
03/23/17
12:08
Periodicals
SSL sues Orbital ATK over claims of confidential data theft, Reuters says »

Space Systems/Loral has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Mar

TRIP

TripAdvisor

$41.40

-0.31 (-0.74%)

, PCLN

Priceline

$1,751.99

4.85 (0.28%)

12:06
03/23/17
03/23
12:06
03/23/17
12:06
Hot Stocks
TripAdvisor strength attributed to takeover speculation »

The intraday move up in…

TRIP

TripAdvisor

$41.40

-0.31 (-0.74%)

PCLN

Priceline

$1,751.99

4.85 (0.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:01
03/23/17
03/23
12:01
03/23/17
12:01
Conference/Events
Stephens transportation analysts hold an analyst/industry conference call »

Transportation Analysts…

BAC

Bank of America

$23.34

0.4 (1.74%)

12:01
03/23/17
03/23
12:01
03/23/17
12:01
Options
Today's four most active single stock options are calls on BofA »

Today's four most…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LMT

Lockheed Martin

$270.93

1.51 (0.56%)

12:01
03/23/17
03/23
12:01
03/23/17
12:01
Hot Stocks
Lockheed Martin to expand production for F-35 components in Johnstown »

Lockheed Martin will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Mar

CEO

CNOOC

$118.68

3.25 (2.82%)

11:59
03/23/17
03/23
11:59
03/23/17
11:59
Upgrade
CNOOC rating change  »

CNOOC upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

POL

PolyOne

$33.38

0.47 (1.43%)

11:59
03/23/17
03/23
11:59
03/23/17
11:59
Conference/Events
PolyOne management to meet with Jefferies »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Mar

  • 27

    Mar

GRBK

Green Brick

11:56
03/23/17
03/23
11:56
03/23/17
11:56
Hot Stocks
Green Brick Partners director acquires 20,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FLXN

Flexion

$19.68

0.14 (0.72%)

, SNY

Sanofi

$45.09

0.42 (0.94%)

11:56
03/23/17
03/23
11:56
03/23/17
11:56
Recommendations
Flexion, Sanofi analyst commentary  »

Flexion CFO departure…

FLXN

Flexion

$19.68

0.14 (0.72%)

SNY

Sanofi

$45.09

0.42 (0.94%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

  • 29

    Mar

  • 10

    May

  • 06

    Oct

SAN

Banco Santander

$6.12

0.005 (0.08%)

11:55
03/23/17
03/23
11:55
03/23/17
11:55
Hot Stocks
Santander to improve consumer protections in Fed agreement »

Santander has agreed to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:55
03/23/17
03/23
11:55
03/23/17
11:55
Conference/Events
Federal Reserve Bank of Minneapolis President speaks at conference »

Minneapolis Federal…

MAA

MAA

$101.99

0.72 (0.71%)

11:54
03/23/17
03/23
11:54
03/23/17
11:54
Conference/Events
MAA management to meet with Jefferies »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

  • 28

    Mar

ADP

ADP

$103.68

0.56 (0.54%)

, CSOD

Cornerstone OnDemand

$38.36

-0.14 (-0.36%)

11:53
03/23/17
03/23
11:53
03/23/17
11:53
Conference/Events
Stephens enterprise software analysts hold an analyst/industry conference call »

Enterprise Software…

ADP

ADP

$103.68

0.56 (0.54%)

CSOD

Cornerstone OnDemand

$38.36

-0.14 (-0.36%)

ORCL

Oracle

$44.97

0.175 (0.39%)

PAYC

Paycom

$54.22

-1.06 (-1.92%)

PCTY

Paylocity

$35.16

-0.16 (-0.45%)

SAP

SAP

$98.09

0.44 (0.45%)

ULTI

Ultimate Software

$193.35

1.24 (0.65%)

WDAY

Workday

$81.64

0.19 (0.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

  • 09

    May

  • 08

    Jun

  • 20

    Jun

TRP

TransCanada

$46.42

0.25 (0.54%)

11:52
03/23/17
03/23
11:52
03/23/17
11:52
Periodicals
State Department expected to approve Keystone XL pipeline permit, Politico says »

The U.S. State Department…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

USO

United States Oil Fund

$10.02

-0.1 (-0.99%)

11:51
03/23/17
03/23
11:51
03/23/17
11:51
Options
Vote of confidence in the US Oil Fund »

Vote of confidence in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BABA

Alibaba

$108.45

2.36 (2.22%)

11:45
03/23/17
03/23
11:45
03/23/17
11:45
Periodicals
Alibaba looking to move beyond China, Nikkei says »

Alibaba is looking to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:45
03/23/17
03/23
11:45
03/23/17
11:45
General news
Breaking General news story  »

Minneapolis Federal…

GOOG

Alphabet

$829.59

-0.87 (-0.10%)

11:42
03/23/17
03/23
11:42
03/23/17
11:42
Periodicals
Google says 'extensive' review of advertising policies begun, Reuters says »

According to Reuters, a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

  • 02

    May

  • 22

    May

TUSK

Mammoth Energy

$19.63

-0.04 (-0.20%)

11:42
03/23/17
03/23
11:42
03/23/17
11:42
Hot Stocks
Mammoth Energy announces successful auction bid to buy frac sand mine, plant »

Mammoth Energy Services…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ESRX

Express Scripts

$63.99

0.15 (0.23%)

11:41
03/23/17
03/23
11:41
03/23/17
11:41
Options
Defensive option play in Express Scripts »

Defensive option play in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.